Congress’ Committee on Oversight and Reform recently detailed a sweeping investigation into “skyrocketing prices of prescription drugs.” The Congressional Committee zeroed in on Celgene and Bristol Myers Squibb in what appears to be price gouging of the critical...
Congress
Category
NCCN® 2019 in San Francisco: Latest Treatment Innovations for Hematologic Malignancies
World-renowned experts on blood cancers are meeting in San Francisco on September 27-28 to help clinicians stay up-to-date on new, practice changing strategies to manage patients with hematologic malignancies at the NCCN 2019 Annual Congress: Hematologic Malignancies™...